Objectives
Trichomonas vaginalis is a risk factor for the acquisition and transmission of HIV. The highly sensitive T. vaginalis nucleic acid amplification test (NAAT) recently became available for routine diagnostic use at our academic medical center in August 2014. The objective of this study was to determine use of this new test among providers at our HIV Clinic, prevalence of T. vaginalis among HIV+ women and men, and predictors of infection.
Methods
Review of clinical and laboratory data of HIV+ women and men presenting to an urban HIV clinic and receiving a T. vaginalis NAAT (on urine, vaginal, or urethral specimens) was performed.